On October 4, 2023, Emisphere Technologies, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of New Jersey on behalf of investors who sold shares of the publicly traded
common stock of Emisphere Technologies, Inc. (“Emisphere” or the “Company”) from November 6, 2020, the announcement date of the merger (“Merger”) between Emisphere and Novo Nordisk A/S (“Novo Nordisk” or “Novo”), through the close of the Merger on December 8, 2020, (the “Class Period”), including investors who sold their shares of Emisphere common stock into the Merger on December 8, 2020.
We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.